About
Cell Therapies, Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalStem Cell & Cellular TherapyAustralia
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
125
By Phase
PHASE4: 1PHASE2: 1
By Status
WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06023368Collaborator
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
PHASE4Withdrawn
Started: Dec 23, 2023 · Completed: Jun 20, 2024
NCT05105035Collaborator
Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
PHASE2Completed
125 participants
Started: Jun 14, 2022 · Completed: Oct 10, 2023
Locations (1)
Headquarters
Sydney, Australia
Map
Loading map...